Ravulizumab (Anti-Complement C5)Ravulizumab (Anti-Complement C5)
Move your mouse over image or click to enlarge

Ravulizumab (Anti-Complement C5)

Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.
Cat# Size Price Qty Buy
A2537-1mg*25 1mg*25
£3,415.00
A2537-1mg*5 1mg*5
£1,138.00
A2537-1mg 1mg
£384.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2537

Related Documents